Avicanna Stock Total Asset
| AVCN Stock | CAD 0.28 0.02 7.69% |
Avicanna fundamentals help investors to digest information that contributes to Avicanna's financial success or failures. It also enables traders to predict the movement of Avicanna Stock. The fundamental analysis module provides a way to measure Avicanna's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avicanna stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 22 M | 23 M | |
| Intangibles To Total Assets | 0.07 | 0.13 |
Avicanna | Total Asset |
Avicanna Company Total Asset Analysis
Avicanna's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Avicanna Total Asset | 21.97 M |
Most of Avicanna's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avicanna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Avicanna Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Avicanna is extremely important. It helps to project a fair market value of Avicanna Stock properly, considering its historical fundamentals such as Total Asset. Since Avicanna's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avicanna's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avicanna's interrelated accounts and indicators.
Click cells to compare fundamentals
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Avicanna Total Assets
Total Assets |
|
Based on the latest financial disclosure, Avicanna has a Total Asset of 21.97 M. This is 99.71% lower than that of the Pharmaceuticals sector and 99.72% lower than that of the Health Care industry. The total asset for all Canada stocks is 99.93% higher than that of the company.
Avicanna Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avicanna's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avicanna could also be used in its relative valuation, which is a method of valuing Avicanna by comparing valuation metrics of similar companies.Avicanna is currently under evaluation in total asset category among its peers.
Avicanna Current Valuation Drivers
We derive many important indicators used in calculating different scores of Avicanna from analyzing Avicanna's financial statements. These drivers represent accounts that assess Avicanna's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avicanna's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 50.9M | 38.5M | 32.2M | 24.3M | 29.6M | 58.5M | |
| Enterprise Value | 51.8M | 39.2M | 33.8M | 26.3M | 31.0M | 59.2M |
Avicanna Fundamentals
| Return On Equity | -1.12 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | (0.29) % | ||||
| Current Valuation | 29.57 M | ||||
| Shares Outstanding | 109.57 M | ||||
| Shares Owned By Insiders | 23.21 % | ||||
| Number Of Shares Shorted | 303.15 K | ||||
| Price To Book | 837.78 X | ||||
| Price To Sales | 1.15 X | ||||
| Revenue | 16.79 M | ||||
| Gross Profit | 1.12 M | ||||
| EBITDA | (6.9 M) | ||||
| Net Income | (7.89 M) | ||||
| Cash And Equivalents | 12.98 M | ||||
| Cash Per Share | 0.66 X | ||||
| Total Debt | 1.8 M | ||||
| Debt To Equity | 6.30 % | ||||
| Current Ratio | 4.31 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | (1.4 M) | ||||
| Short Ratio | 1.26 X | ||||
| Earnings Per Share | (0.10) X | ||||
| Target Price | 0.7 | ||||
| Number Of Employees | 87 | ||||
| Beta | 1.43 | ||||
| Market Capitalization | 27.94 M | ||||
| Total Asset | 21.97 M | ||||
| Retained Earnings | (98.71 M) | ||||
| Working Capital | (3.51 M) | ||||
| Net Asset | 21.97 M |
About Avicanna Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avicanna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avicanna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avicanna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Avicanna Stock
Avicanna financial ratios help investors to determine whether Avicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.